Health stocks perform well in 2022.Tmo seemed a quite a deal for me, PE ratio(29, fwd: 25) seems fine comparing it's peers.Also historic Pe ratio of company seems fine. Price movement made a reversal to upwards from 50 ema(weekly) which also offers an entry opportunity.Last balance sheet is excellent with significant income and revenue increases.New earnings will be announced in 28th of April.I will appreciate your comments if i miss anything.Thanks in advance.
Leave a Reply